Novel gene therapy for hemophilia A leads to sustained expression of clotting factor and reduced bleeding events
A novel gene therapy for hemophilia A led to sustained expression of the clotting factor those patients lack, resulting in a reduction—or in some cases complete elimination—of painful and potentially life-threatening ...
Nov 17, 2021
0
9